Joachim Drevs

Liver cancer: Targeted future options.

Andreas Pircher, J. Drevs, A. Pircher, 2011, World journal of hepatology.

Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours.

Jürgen Hennig, Eric Masson, Yu-Yun Ho, 2005, European journal of cancer.

Receptor tyrosine kinases: the main targets for new anticancer therapy.

J. Drevs, C. Unger, M. Medinger, 2003, Current drug targets.

Metronomic Antiangiogenic Therapy with Capecitabine and Celecoxib in Advanced Tumor Patients – Results of a Phase II Study

Jürgen Hennig, Ralph Strecker, J. Hennig, 2007, Oncology Research and Treatment.